Patient Leaflet Updated 29-Sep-2025 | Synchrony Pharma Ltd
Isoprenaline Hydrochloride 1 mg/5 ml concentrate for solution for infusion
Isoprenaline Hydrochloride 1 mg/5 ml concentrate for solution for infusion
isoprenaline hydrochloride
The name of your product is Isoprenaline Hydrochloride 1 mg/5 ml concentrate for solution for infusion but it will be referred to as Isoprenaline throughout this leaflet.
1. What Isoprenaline is and what it is used for
2. What you need to know before you are given Isoprenaline
3. How Isoprenaline is given
4. Possible side effects
5. How to store Isoprenaline
6. Contents of the pack and other information
Isoprenaline contains the active substance isoprenaline, which has a stimulating effect on a certain part of the nervous system (sympathomimetic). Isoprenaline leads to, among other things, increased heart rate, increased heart contractility and dilatation of blood vessels, which decreases blood pressure.
Isoprenaline is used for the short-term treatment of:
Talk to your doctor or nurse before you are given Isoprenaline:
Tell your doctor if you are using, have recently used or might use any other medicines.
This is particularly important if you are taking any of the following medicines:
Isoprenaline may not be administered under chloroform, cyclopropane or halothane anaesthetics or any other halogen anaesthetic.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
If you are pregnant, this medicine may only be used if the doctor considers it absolutely necessary.
The administration of Isoprenaline during the breast-feeding period is not recommended.
This medicine contains approx. 16.5 mg sodium (main component of cooking/table salt) in each 5 ml of sterile solution. This is equivalent to approx. 0.8 % of the recommended maximum daily dietary intake of sodium for an adult.
This medicine will be administered to you by intravenous (into a vein) infusion by a specialist doctor.
The doctor will decide the best suitable dose for you.
The medicine will be diluted in a physiological saline or isotonic glucose solution.
The doctor will carefully increase the dose of Isoprenaline while closely monitoring your heart rate.
Isoprenaline is not meant to be used routinely.
The symptoms of overdose are nausea, headaches, extra heart beats and heart rate acceleration.
If you think you were given more Isoprenaline than you should, contact your doctor or nurse immediately.
If necessary, a plasma or complete blood transfusion may be performed.
If you have any further questions on the use of this medicine, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Not known (frequency cannot be estimated from the available data):
If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for ‘MHRA Yellow Card’ in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the outer carton and ampoule labels after “EXP”. The expiry date refers to the last day of that month.
Store below 30 ℃.
Store in the original package in order to protect from light.
From a microbiological point of view, diluted solutions should be used immediately. If not used immediately, in-use storage times and conditions prior to use of the diluted solution are the responsibility of the user and would normally not be longer than 24 hours.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Isoprenaline Hydrochloride 1 mg/5 ml concentrate for solution for infusion is a clear, colourless solution, practically free from visible particles.
It is supplied in clear colourless type I glass ampoules with a white fracture crack, containing 5 ml.
Packages of 5 ampoules.
This leaflet was last revised in February/2025
3 Bunhill Row, London, EC1Y 8YZ
+44 (0)20 7821 2840
www.cnx-therapeutics.com